Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer
2023-06-07
(Press-News.org)
“[...] large multicenter prospective randomized trials are needed to provide the clinical evidence for the use of [chemotherapy] in second line and third-line post [immunotherapy] failure.”
BUFFALO, NY- June 7, 2023 – A new research paper was published in Oncotarget's Volume 14 on May 26, 2023, entitled, “Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC).”
Lung cancer is the number one cause of mortality among all types of cancer worldwide. Its treatment landscape has shifted from the classic chemotherapy alone to newer regimens based on the discovery of new immunotherapy and targeted therapy drugs. However, chemotherapy is still an option for treatment of advanced non-small cell lung cancer (NSCLC) after progression on immunotherapy alone or in combination with first-line chemotherapy.
This new retrospective study, by researchers Hazem I. Assi, Maroun Bou Zerdan, Mohammad Hodroj, Makram Khoury, Nour Sabiha Naji, Ghid Amhaz, Reine Abou Zeidane, and Fadi El Karak from the American University of Beirut Medical Center and Hotel Dieu de France University Hospital, was based on chart review of patients diagnosed with advanced NSCLC cases who received Docetaxel as second or third line after being treated by immunotherapy and/or chemotherapy in previous lines. The data was collected from the medical records of physicians’ clinics in three different hospital centers in Lebanon over the period of 5 years from July 2015 until December 2020. February 2021 was data analysis cut off time.
“The main aim [of this study] was to assess the role of Docetaxel post-chemoimmunotherapy for patients with diagnosed NSCLC.”
A total of 21 patients were included in this study. The majority of our patients were males (81%). As for histologic type, most patients had non-squamous lung cancer (67%) as compared to 33% who had squamous lung cancer. Overall, their study reported a 24% response rate to Docetaxel including stable disease and partial response and a median progression free survival (PFS) of 3 months. The mean time interval elapsed from diagnosis to the initiation of Docetaxel was 11.5 months.
“New therapeutic options should be validated for the treatment of NSCLC in the second and subsequent lines of therapy considering the poor prognosis of this disease. The chemotherapy in second and third line may keep an important role in the treatment after progression on newer agents, but it needs more evidence in prospective studies including a larger number of patients.”
Read the full paper: DOI: https://doi.org/10.18632/oncotarget.28444
Correspondence to: Fadi El Karak
Email: Felkarak@yahoo.com
Keywords: chemotherapy, immunotherapy, non-small cell lung cancer
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2023-06-07
ACM, the Association for Computing Machinery, today announced that Kunle Olukotun, a Professor at Stanford University, is the recipient of the ACM-IEEE CS Eckert-Mauchly Award for contributions and leadership in the development of parallel systems, especially multicore and multithreaded processors.
In the early 1990s, Olukotun became a leading designer of a new kind of microprocessor known as a “chip multiprocessor”—today called a “multicore processor.” His work demonstrated the performance advantages of multicore processors ...
2023-06-07
Plant biologist Alex Harkess, PhD, and his lab at HudsonAlpha Institute for Biotechnology are on a mission to change the future of food and fiber crops, one flowering plant species at a time. Much of plant breeding and global food production relies on the pollination of flowers to produce fruits that are eaten and used to produce further progeny. This process might sound straightforward, but it is actually complicated by the fact that some flowers contain only male or female reproductive organs, others contain both (hermaphrodites), and some can even switch sexes.
How flowers become male, ...
2023-06-07
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments include a molecularly driven Phase I trial of the ATR inhibitor camonsertib, an artificial intelligence model to predict immunotherapy responses in lung cancer, an analysis of cognitive and functional outcomes following treatment ...
2023-06-07
Key messages
Despite ongoing structural changes, small-scale processors, grocers, market vendors and food service operators dominate the food systems of most low- and lower middle-income countries;
Unsafe food is widespread in informal food distribution channels, having national public health implications;
Very few countries have coherent strategies for tackling food safety risks in the informal sector;
Most of the policy attention and resources now devoted to domestic food safety in the developing world focuses on strengthening ...
2023-06-07
PROVIDENCE, R.I. [Brown University] — The risks of exposure to “forever chemicals” start even before birth, a new study confirms, potentially setting up children for future health issues.
Exposure to per- and polyfluoroalkyl substances (PFAS) during pregnancy was linked to slightly higher body mass indices and an increased risk of obesity in children, according to a new Environmental Health Perspectives study led by Brown University researchers.
While this link has been suggested in previous research, the data has been inconclusive. The new study, which was funded by the Environmental Influences on Child Health Outcomes program ...
2023-06-07
NASA's Parker Solar Probe (PSP) has flown close enough to the sun to detect the fine structure of the solar wind close to where it is generated at the sun's surface, revealing details that are lost as the wind exits the corona as a uniform blast of charged particles.
It's like seeing jets of water emanating from a showerhead through the blast of water hitting you in the face.
In a paper to be published this week in the journal Nature, a team of scientists led by Stuart D. Bale, a professor of physics at the University of California, Berkeley, and James Drake of the University of Maryland-College ...
2023-06-07
About The Study: Among individuals with or at risk for cardiovascular disease, fewer than 1 in 4 use wearable devices, with only half of those reporting consistent daily use, according to the results of this study based on a nationally representative sample of U.S. adults in 2019 and 2020. As wearable devices emerge as tools that can improve cardiovascular health, the current use patterns could exacerbate disparities unless there are strategies to ensure equitable adoption.
Authors: Rohan Khera, M.D., M.S., of the Yale School of Medicine in New Haven, Connecticut, is the corresponding author.
To ...
2023-06-07
La Jolla, Calif. (June 5, 2023) — What does ChatGPT say when you tell it you were sexually assaulted, want to commit suicide, or are trying to quit smoking?
A new study published in JAMA Network Open led by John W. Ayers, Ph.D., from the Qualcomm Institute within the University of California San Diego, provides an early look into how artificially intelligent (AI) assistants could help answer public health questions.
Already, hundreds of millions use AI assistants like ChatGPT, and it will change the way the public accesses information. Given the growth of AI assistant use, the scientific team evaluated ...
2023-06-07
The discovery of a “lost world” of ancient organisms that lived in Earth’s waterways at least 1.6 billion years ago could change our understanding of our earliest ancestors.
Known as the ‘Protosterol Biota’, these microscopic creatures are part of a family of organisms called eukaryotes. Eukaryotes have a complex cell structure that includes mitochondria, known as the “powerhouse” of the cell, and a nucleus that acts as the “control and information centre”. ...
2023-06-07
Newly discovered biomarker signatures point to a whole range of previously unknown organisms that dominated complex life on Earth about a billion years ago. They differed from complex eukaryotic life as we know it, such as animals, plants and algae in their cell structure and likely metabolism, which was adapted to a world that had far less oxygen in the atmosphere than today. An international team of researchers, including GFZ geochemist Christian Hallmann, now reports on this breakthrough for the field of evolutionary geobiology in the journal Nature.
The previously unknown “protosteroids” were ...
LAST 30 PRESS RELEASES:
[Press-News.org] Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer
